Literature DB >> 3983533

Serum lipids and lipoproteins in patients with primary gout.

A Ulreich, G M Kostner, K P Pfeiffer, P Sedlmayr, F Rainer.   

Abstract

Serum lipid and lipoprotein values of 32 male patients suffering from gout were quantitated and compared with corresponding values of a random control group which did not differ significantly with regard to age, body weight index and socio-economic status. All patients were on therapy with allopurinol which lasted on average for 6 years. The most striking differences between patients and controls were the increased triglyceride and apo B values and the decreased HDL-cholesterol (HDL-C) and HDL-phospholipid (HDL-PL) values in the patient group. The values of total cholesterol, LDL-cholesterol, apo A-I and Lp (a) were not significantly different between patients and controls. The great differences in the ratios of apo B/LDL-C, apo A-I/HDL-C and apo A-I/HDL-PL values suggest that gout is connected with changes in the chemical composition of the major lipoprotein classes. In three normolipemic individuals who were treated for 3 weeks with allopurinol no changes in lipoproteins and apolipoproteins were apparent. The results are discussed in view of the atherosclerosis risk of patients suffering from gout.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 3983533     DOI: 10.1007/bf00270300

Source DB:  PubMed          Journal:  Rheumatol Int        ISSN: 0172-8172            Impact factor:   2.631


  26 in total

1.  Gout and serum cholesterol.

Authors:  J H BECKER
Journal:  Wis Med J       Date:  1960-12

2.  [Investigations concerning the incidence of disorders of lipid and carbohydrate metabolism in primary gout and symptomless hyperuricaemia (author's transl)].

Authors:  O Frank
Journal:  Wien Klin Wochenschr       Date:  1974-05-03       Impact factor: 1.704

3.  Gout and its relation to lipid metabolism. I. Serum uric acid, lipid, and lipoprotein levels in gout.

Authors:  H Mielants; E M Veys; A de Weerdt
Journal:  Ann Rheum Dis       Date:  1973-11       Impact factor: 19.103

4.  Plasma lipid levels in gout.

Authors:  L G Darlington; J T Scott
Journal:  Ann Rheum Dis       Date:  1972-11       Impact factor: 19.103

5.  Correlations among hyperuricemia, hypercholesterolemia, coronary disease and hypertension.

Authors:  A P Hall
Journal:  Arthritis Rheum       Date:  1965-10

6.  [HDL-cholesterol in patients with gout (author's transl)].

Authors:  H Yamanaka; T Watanabe; T Kawai; K Nishioka; I Sakurabayashi; K Mikanagi
Journal:  Ryumachi       Date:  1981-03

7.  Separation and quantitation of subclasses of human plasma high density lipoproteins by a simple precipitation procedure.

Authors:  L I Gidez; G J Miller; M Burstein; S Slagle; H A Eder
Journal:  J Lipid Res       Date:  1982-11       Impact factor: 5.922

8.  Relation of angiographically defined coronary artery disease to plasma lipoprotein subfractions and apolipoproteins.

Authors:  N E Miller; F Hammett; S Saltissi; S Rao; H van Zeller; J Coltart; B Lewis
Journal:  Br Med J (Clin Res Ed)       Date:  1981-05-30

9.  Changing trends of mortality in gout.

Authors:  T Yü; J H Talbott
Journal:  Semin Arthritis Rheum       Date:  1980-08       Impact factor: 5.532

10.  Risk factors for peripheral atherosclerosis. Retrospective evaluation by stepwise discriminant analysis.

Authors:  E Pilger; H Pristautz; K P Pfeiffer; G Kostner
Journal:  Arteriosclerosis       Date:  1983 Jan-Feb
View more
  5 in total

Review 1.  EULAR evidence based recommendations for gout. Part I: Diagnosis. Report of a task force of the Standing Committee for International Clinical Studies Including Therapeutics (ESCISIT).

Authors:  W Zhang; M Doherty; E Pascual; T Bardin; V Barskova; P Conaghan; J Gerster; J Jacobs; B Leeb; F Lioté; G McCarthy; P Netter; G Nuki; F Perez-Ruiz; A Pignone; J Pimentão; L Punzi; E Roddy; T Uhlig; I Zimmermann-Gòrska
Journal:  Ann Rheum Dis       Date:  2006-05-17       Impact factor: 19.103

2.  Hyperuricemia-hyperlipemia association in the absence of obesity and alcohol abuse.

Authors:  E Collantes Estevez; M Pineda Priego; J Añon Barbudo; P Sanchez Guijo
Journal:  Clin Rheumatol       Date:  1990-03       Impact factor: 2.980

3.  Renal excretion of urate by hyperuricaemic-hyperlipidemic patients.

Authors:  E Collantes Estevéz; F J Tinahones Madueño; A González Ruiz; J Añón Barbudo; M Pineda Priego; P Sánchez Guijo
Journal:  Clin Rheumatol       Date:  1992-12       Impact factor: 2.980

4.  The relationship of apolipoprotein B and very low density lipoprotein triglyceride with hyperuricemia and gout.

Authors:  Humaira Rasheed; Angela Hsu; Nicola Dalbeth; Lisa K Stamp; Sally McCormick; Tony R Merriman
Journal:  Arthritis Res Ther       Date:  2014-11-29       Impact factor: 5.156

5.  Effects of Uric Acid on Lipid Levels in CKD Patients in a Randomized Controlled Trial.

Authors:  Rodney G Bowden; Brian D Shelmadine; Jennifer J Moreillon; Erika Deike; Jackson O Griggs; Ronald L Wilson
Journal:  Cardiol Res       Date:  2013-05-09
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.